Probable West Nile Virus hepatitis: Case report

Gould, 2008, Pathogenic flaviviruses, Lancet, 371, 500, 10.1016/S0140-6736(08)60238-X Khare, 2022, The Japanese encephalitis antigenic complex viruses: from structure to immunity, Viruses, 14, 2213, 10.3390/v14102213 Campbell, 2002, West Nile virus, Lancet Infect Dis, 2, 519, 10.1016/S1473-3099(02)00368-7 Riccò, 2021, Epidemiology of West Nile Virus Infections in Humans, Italy, 2012-2020: A summary of available evidences, Trop Med Infect Dis, 6, 61, 10.3390/tropicalmed6020061 Sejvar, 2014, Clinical manifestations and outcomes of West Nile virus infection, Viruses, 6, 606, 10.3390/v6020606 Bampali, 2022, West Nile disease symptoms and comorbidities: a systematic review and analysis of cases, Trop Med Infect Dis, 7, 236, 10.3390/tropicalmed7090236 Sampson, 2000, The pathology of human West Nile Virus infection, Hum Pathol, 31, 527, 10.1053/hp.2000.8047 Yim, 2004, Spectrum of clinical manifestations of West Nile virus infection in children, Pediatrics, 114, 1673, 10.1542/peds.2004-0491 Georges, 1987, Fatal hepatitis from West Nile virus, Ann De l′Inst Pasteur/Virol, 138, 237, 10.1016/S0769-2617(87)80007-2 Piantadosi, 2020, Diagnostic approach for arboviral infections in the United States, J Clin Microbiol, 58, 10.1128/JCM.01926-19 Sinigaglia, 2020, New avenues for therapeutic discovery against West Nile virus, Expert Opin Drug Discov, 15, 333, 10.1080/17460441.2020.1714586 Pacenti, 2019, Clinical and virological findings in patients with Usutu virus infection, northern Italy, 2018, Eur Surveill, 24, 10.2807/1560-7917.ES.2019.24.47.1900180 Istituto Superiore di Sanità (ISS). Bollettino N. 20 del 02/11/2022. Pierson, 2020, The continued threat of emerging flaviviruses, Nat Microbiol, 5, 796, 10.1038/s41564-020-0714-0